RE: getting worried29 Oct 2020 10:42
Wow.
We have just had £80million invested into the company at 175p. This drop is inconsequential.
We know that this drug works on respiratory diseases as has been proven time and time again. I will repeat again.
The data shows:
It works in the LAB
It works in ASTHMA patients
It works in COPD patients
It works in COVID patients.
Covid has accelerated the development of this drug enabling it to get through a phase 2 and 3 trials within a 12 month period. This just does not happen in the pharma world!
Stay patient, ignore the noise and wait for phase 3 to complete. If you want a quick return try a junior gold explorer!